Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cordis Corporation Resolves Corporate Warning Letter - Medical Product Outsourcing

Cordis Corporation Resolves Corporate Warning Letter

Cordis Corp. has recieved FDA notification that previosly outlined issues have been resolved.

Cordis Corporation today announced that it has received notification from the U.S. Food and Drug Administration (FDA) that all items outlined in the company’s warning letter have been resolved.

“We are pleased that the FDA warning letter is now resolved,” said Rick Anderson, Company Group Chairman, Cordis Corporation. “This is an important achievement for Cordis. We are committed to ensuring that our systems and procedures continue to provide for quality products and services that fulfill the clinical needs of interventional cardiologists.”

About Cordis Corporation

Cordis Corporation, a Johnson & Johnson company, is a worldwide leader in the development and manufacture of interventional vascular technology. Through the company’s innovation, research and development, Cordis partners with interventional cardiologists worldwide to treat millions of patients who suffer from vascular disease.

More information about Cordis Corporation can be found at www.cordis.com.

SOURCE: CORDIS CORPORATION

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters